In short the two studies are very different in design. Firstly study Geno 003 Phase I was in HSV-2 positive people whereas ours was in HSV-2 negative people so we couldn’t compare viral shedding numbers. Our next study will be in these positive people.
- Forums
- ASX - By Stock
- AVR
- Article on news.com.au
AVR
anteris technologies global corp.
Add to My Watchlist
1.25%
!
$4.86

Article on news.com.au, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.86 |
Change
0.060(1.25%) |
Mkt cap ! $75.35M |
Open | High | Low | Value | Volume |
$4.96 | $4.96 | $4.86 | $17.88K | 3.628K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1026 | $4.86 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.00 | 800 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1026 | 4.860 |
1 | 1000 | 4.840 |
1 | 54 | 4.810 |
1 | 209 | 4.780 |
1 | 1000 | 4.750 |
Price($) | Vol. | No. |
---|---|---|
5.000 | 800 | 1 |
5.070 | 120 | 1 |
5.150 | 4449 | 1 |
5.200 | 2136 | 2 |
5.310 | 973 | 1 |
Last trade - 16.10pm 23/07/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |